Crown Bioscience Inc. is company involved in advancing anti-cancer therapeutics through the preclinical and drug development stages. The company is headquartered in Silicon Valley, with research facilities on Beijing and Taicang campuses, (China) and in Indianapolis. A majority of Crown Bioscience scientists are highly trained PhD and MS scientists.
The scientists are engaged in the design and execution of pre-clinical drug development program using AAALAC approved animal facilities, proprietary animal models, and in vivo surgical expertise.